FRM
TMO icon

Fox Run Management’s Thermo Fisher Scientific TMO Stock Holding History

Fox Run Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
+4,373
New +$2.1M 0.36% 13
2026
Q1 		– Sell
-2,101
Closed -$1.22M – 1237
2025
Q4 		$1.22M Buy
+2,101
New +$1.19M 0.19% 135
2025
Q3 		– Sell
-4,885
Closed -$1.98M – 1239
2025
Q2 		$1.98M Buy
4,885
+3,087
+172% +$1.29M 0.33% 28
2025
Q1 		$895K Buy
1,798
+985
+121% +$533K 0.14% 238
2024
Q4 		$423K Sell
813
-784
-49% -$431K 0.08% 494
2024
Q3 		$988K Sell
1,597
-604
-27% -$358K 0.22% 129
2024
Q2 		$1.22M Buy
+2,201
New +$1.26M 0.23% 123
2024
Q1 		– Sell
-1,753
Closed -$930K – 1059
2023
Q4 		$930K Buy
+1,753
New +$849K 0.24% 105
2022
Q2 		– Sell
-429
Closed -$253K – 745
2022
Q1 		$253K Buy
+429
New +$246K 0.14% 335
2021
Q2 		– Sell
-756
Closed -$345K – 445
2021
Q1 		$345K Buy
+756
New +$361K 0.62% 46
2020
Q1 		– Sell
-933
Closed -$303K – 357
2019
Q4 		$303K Buy
+933
New +$283K 0.24% 196
2019
Q1 		– Sell
-1,484
Closed -$332K – 690
2018
Q4 		$332K Sell
1,484
-1,052
-41% -$247K 0.18% 238
2018
Q3 		$619K Sell
2,536
-2,188
-46% -$503K 0.27% 105
2018
Q2 		$979K Buy
4,724
+1,468
+45% +$312K 0.31% 34
2018
Q1 		$672K Buy
+3,256
New +$683K 0.16% 210
2017
Q3 		– Sell
-2,800
Closed -$489K – 862
2017
Q2 		$489K Sell
2,800
-1,100
-28% -$185K 0.17% 228
2017
Q1 		$599K Buy
+3,900
New +$596K 0.24% 132

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fox Run Management's TMO Position: Q2 2026 in Review

Fox Run Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 4,373 shares worth $2.19M. The stake represents 0.36% of the portfolio and ranks #13 among its holdings. This is a return to the name: Fox Run Management previously reported a position in TMO as recently as Q4 2025.

Fox Run Management first reported a position in TMO in Q1 2017 and has held it in 17 quarters since. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fox Run Management held 4,373 shares of Thermo Fisher Scientific worth $2.19M as of Q2 2026.
  • Thermo Fisher Scientific was a new Fox Run Management position in Q2 2026.
  • Thermo Fisher Scientific made up 0.36% of Fox Run Management's portfolio in Q2 2026, its #13 holding.
  • Fox Run Management first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 17 quarters since.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.